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Increased frequency of G-protein b3-subunit 825 T allele in in IgA glomerulonephritis, in which Schmid et al and
dialyzed patients with type 2 diabetes. Boulahrouz et al found a higher frequency of hyperten-
Background. A polymorphism (C825T) in exon 10 of the sion in parents of propositi than in parents of controlgene encoding the b3 subunit of heterotrimeric G proteins
individuals [1, 2]. Evidence for a role of genetic predispo-(GNb3) has recently been described, and the T allele was
sition to hypertension was also provided in patients withfound to be associated with late-onset hypertension. Because
hypertension is a known risk factor for the development of type 2 diabetes and nephropathy. Strojek et al examined
clinically manifest progressive renal disease, we examined the the offspring of patients with type 2 diabetes with or
C825T polymorphism in older hemodialysis patients suffering without nephropathy [3], and found that the offspringfrom nondiabetic renal disease or type 2 diabetes with pre-
of parents with type 2 diabetes plus nephropathy hadsumed diabetic nephropathy, respectively, and in older healthy
significantly higher blood pressure values.controls.
Methods. Genotyping was performed by polymerase chain Recently, Siffert et al described a polymorphism of
reaction, followed by restriction enzyme analysis. the b3 subunit of G proteins, which was associated withResults. The study showed that the frequency of the T allele
late-onset hypertension [4]. The rationale for examiningin the nondiabetic patients on dialysis (0.232) was significantly
the G protein was based on previous findings that in im-(P , 0.03) lower than in older healthy controls (0.293). In
contrast, the frequency was significantly (P , 0.02) higher in mortalized B cells of patients with essential hypertension,
older patients with type 2 diabetes on dialysis. No significant the pH-dependent activation kinetics of the sodium pro-
change in T-allele frequency was noted in older patients with ton exchanger, which is a G-protein controlled process,
type 2 diabetes without microangiopathy (0.286). The odds
were increased [5]. This was also specifically true in pa-ratios for patients with type 2 diabetes on dialysis versus nondi-
tients with type 1 diabetes and diabetic nephropathy [6].abetic patients on dialysis were 3.24 (1.3 to 7.9, P , 0.00079)
for TT/CC and 1.82 (1.07 to 3.09, P , 0.02) for CT/CC. The Based on these observations, we reasoned that the
respective odds ratios for patients with type 2 diabetes on hypertension-associated T allele of this polymorphism
dialysis versus controls were 2.05 (1.07 to 3.9, P , 0.028) for should be enriched in a population of older dialysis pa-
CT/CC and 1.216 (0.79 to 1.87; P , 0.37) for CT/CC.
tients with or without type 2 diabetes. Our study wasConclusion. The data do not support a role of the hyperten-
carried out to test this hypothesis.sion-associated T allele in the genesis of dialysis-dependent
end-stage renal failure in general, but are compatible with a
specific role of the T allele in the development or progression
METHODSof diabetic nephropathy.
Patients
All available patients with the onset of hemodialysis
Several observations point to genetic predisposition treatment after the age of 60 years were recruited from
of hypertension as an important factor determining the the dialysis centers in Heidelberg, Heilbronn, Mann-
presence of clinically manifest renal disease. This is true heim-Ka¨fertal, Villingen-Schwenningen, and Wiesloch
(Table 1). Of these patients, 125 had nondiabetic renal
disease, and 130 had type 2 diabetes according to Na-Key words: hypertension, diabetic nephropathy, renal failure, progres-
sive renal disease, CT polymorphism. tional Diabetes Data Group criteria [7]. Of the nondia-
betic patients, 29 had glomerulonephritis, 22 autosomalReceived for publication August 7, 1998
dominant polycystic kidney disease (ADPKD), 9 analge-and in revised form December 1, 1998
Accepted for publication December 3, 1998 sic nephropathy, 9 urological problems, and 56 were of
unknown or other causes. In addition, patients (a) with 1999 by the International Society of Nephrology
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Table 1. Characteristics of our study population
Elderly patients
Elderly patients Elderly patients with type 2 diabetes
on dialysis on dialysis without microangiopathy
without type 2 with type 2 (microalbuminuria,
diabetes diabetes retinopathya) Controls
N 125 130 77 357
Age yearsb 7167.2 70.867.0 64.369.7 56.7 64.4
Gender distribution
female/male 59/56 58/72 44/33 141/216
Duration of
hemodialysis years 5.9965.36 3.28 62.44 — —
a Data given as mean 6 standard deviation
b Known duration of type 2 diabetes . 5 years
a known duration of diabetes of more than five years, RESULTS
(b) who were above age 50 years, or (c) who were without Table 2 shows the genotype distribution, and Table 3
evidence of microalbuminuria or retinopathy were re- lists the allele frequency in the study population. All
cruited from the diabetes outpatient clinic in Heidelberg. groups complied to the Hardy Weinberg equilibrium,
Random controls were all available blood donors above with the exception of the group of older patients with
age 50 from the Department of Transfusion Medicine, type 2 diabetes and no evidence of microangiopathy.
Essen, Germany. None of these individuals were on any The T allele was significantly less frequent in nondia-
medication. betic older patients on dialysis than in the older blood
The study was approved by the local ethics committee, donors (Table 3), but it was significantly more frequent
and all patients gave written informed consent. in patients with type 2 diabetes on dialysis, but not in
patients with type 2 diabetes without microangiopathy.
DNA genotyping The ORs for dialysis-dependent patients with type 2
From each patient, 10 ml of ethylenediaminetetraace- diabetes versus nondiabetic patients on dialysis were 3.24
tic acid (EDTA) blood were drawn for isolation of geno- (1.3 to 7.9, P , 0.00079) for TT/CC, 1.82 (1.07 to 3.09,
mic DNA according to standard procedures. Genotyping P , 0.02) for CT/CC, and 2.05 (1.24 to 3.37, P , 0.0047)
was performed by polymerase chain reaction (PCR), for (TT 1 CT)/CC. The ORs for dialysis-dependent pa-
followed by restriction enzyme analysis of the resulting tients with type 2 diabetes versus controls were 2.05 (1.07
products [4]. PCR was performed with 200 ng of genomic to 3.9, P , 0.028) for TT/CC, 1.22 (0.79 to 1.87, P ,
DNA and primers GP-1 (sense, 5-TGACCCACTTG 0.37) for CT/CC, and 1.36 (0.9 to 2.03, P , 0.14) for
CCACCCGTGC-39) and GP-2 (antisense, G9-GCAG- (TT 1 CT)/CC.
CAGCCAGGGCTGGC-39) in a reaction volume of 50
ml. Reaction conditions were per cycle as follows: dena-
DISCUSSIONturation at 948C for 45 seconds, annealing at 608C for
45 seconds, and elongation at 728C for 45 seconds. All The study was designed to examine the working hy-
together, 35 cycles were performed. Reaction products pothesis that the hypertension-associated T allele of the
were digested with the restriction enzyme BseDI (MBI Gb3 polymorphism [4] is associated with progressive
Fermentas) and were analyzed on 1.7% agarose or 2% nephropathy leading to end-stage renal failure in older
metaphor agarose gels, stained with ethidium bromide, patients. The results in nondiabetic patients clearly do
and visualized under ultraviolet illumination. The undi- not support this hypothesis. Indeed, the T allele was
gested PCR product (TT genotype) gave a band of 268 found less frequently in this population, and this may be
bp in size. The completely digested PCR product (CC due to the association of the T allele with hypertension
genotype) generated two bands of 152 bp and 116 bp, [4], particularly low renin hypertension and elevated dia-
respectively. Thus, heterozygotes (CT genotype) pro- stolic blood pressures [8], and thus presumably higher
duced three bands of 268 bp, 152 bp, and 116 bp. cardiovascular mortality, which is blood pressure related
in dialysis patients [9]. This point is relevant because the
Statistical analysis average duration of dialysis was rather long.
In contrast, however, the unanticipated result was aData are given as mean and standard deviation (sd).
Genotype distributions, allele frequencies, and odds ra- higher gene frequency of the T allele found in patients
with type 2 diabetes who were on maintenance hemodial-tios (ORs) were compared between groups using the
chi-squared test. ysis. Although no specific information on the activity
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Table 2. Genotypes of our study population
Elderly patients on Elderly patients on Elderly patients with type 2 diabetes
dialysis without type 2 dialysis with type 2 without microangiopathy
diabetes diabetes (microalbuminuria, retinopathy) Controls
N 125 130 77 357
CC 75 (60%) 55 (42.3%) 34 (44.2%) 178 (49.9%)
CT 42 (33.6%) 56 (43%) 42 (54.5%) 149 (41.7%)
TT 8 (6.4%)a 19 (14.6%)bc 1 (1.3%) 30 (8.4%)
CC, CT, and TT are defined in the Methods section.
a P , 0.147 vs. control
b P , 0.089 vs. control
c P , 0.006 vs. type 2 without microangiopathy
Table 3. Allele frequencies of our study population
Elderly patients on Elderly patients on Elderly patients with type 2 diabetes
dialysis without type 2 dialysis with type 2 without microangiopathy
diabetes diabetes (microalbuminuria, retinopathy) Controls
N 125 130 77 357
C 0.768 0.638 0.714 0.707
T 0.232a 0.362bc 0.286 0.293
a P , 0.002 vs. control
b P , 0.001 vs. control
c P , 0.0003 vs. type 2 without microangiopathy
of G-protein–controlled transport processes in type 2 sumably genetic determination, of end-stage renal fail-
ure, particularly in diabetic patients [11, 12].diabetes with nephropathy is currently available, it is of
These results provide an interesting working hypothe-note that Pietruck et al found higher G-protein activation
sis, but we emphasize that the hypothesis needs to bein lymphoblasts grown from patients with type 1 diabetes
confirmed by further studies.and nephropathy compared with type 1 diabetic patients
without nephropathy [6]. In view of the high cardiovascu-
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